PMID: 6990112Jan 1, 1980Paper

Clinical role of the mixed cell agglutination test in the prospective management of superficial bladder tumors

Journal of Surgical Oncology
J D JohnsonH M Radwin

Abstract

The mixed cell agglutination test allows the selection of patients with transitional cell carcinoma of the bladder who are at risk to develop invasive disease. A review of our retrospective experience and that of others reveals an overall accuracy of 78% in the prediction of tumor behavior. Current prospective studies are described and a rational, selective approach to the follow-up of bladder tumor patients, influenced by the MCA test result, is advocated.

References

Jun 1, 1972·American Journal of Clinical Pathology·I Davidsohn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.